nonproliferative diabetic retinopathy

DEFINITION of nonproliferative diabetic retinopathy

Nonproliferative diabetic retinopathy (NPDR) — also called background retinopathy — is a microvascular complication of diabetes mellitus in which chronic hyperglycemia damages the small blood vessels (capillaries) supplying the retina. The hallmark distinguishing NPDR from its more advanced counterpart, proliferative diabetic retinopathy (PDR), is the complete absence of retinal neovascularization (new, abnormal blood vessel growth). Pathophysiology begins with loss of pericytes (structural support cells lining retinal capillaries), followed by breakdown of the blood-retinal barrier, formation of microaneurysms (focal outpouchings of capillary walls), and progressive capillary occlusion leading to retinal ischemia. As ischemia worsens, VEGF (vascular endothelial growth factor) is upregulated — the molecular trigger that drives conversion to PDR. NPDR is classified into three stages by the ETDRS (Early Treatment Diabetic Retinopathy Study) severity scale and international consensus:

Stage	Key Findings
Mild NPDR	Microaneurysms only
Moderate NPDR	More microaneurysms, dot-and-blot hemorrhages, hard exudates, cotton-wool spots
Severe NPDR	”4-2-1 Rule”: hemorrhages/MAs in all 4 quadrants, OR venous beading in ≥2 quadrants, OR IRMA in ≥1 quadrant

Diabetic macular edema (DME) — fluid accumulation at the macula — can occur at any stage of NPDR and is the leading cause of vision loss in diabetic patients. Management is primarily through glycemic control, blood pressure management, and monitoring; anti-VEGF injections (e.g., Eylea, Lucentis, Avastin) are the standard of care for center-involving DME.

---

ETYMOLOGY of nonproliferative diabetic retinopathy

latin The term is a compound of four components:

Element	Origin	Meaning
Non-	latin non	”not” — the negating prefix
Proliferative	Latin proles (“offspring”) + ferre (“to bear”) + -ive	”tending to produce new growth”; in medicine, abnormal new vessel formation
Diabetic	greek diabētēs (διαβήτης) = “siphon”	Referring to the excessive urination characteristic of diabetes; from dia- (“through”) + bainein (“to go”)
Retinopathy	Latin rete (“net”) + Greek -pathy (pathos, “disease/suffering”)	“disease of the retina” — the net-like layer of sensory tissue at the back of the eye

The full term was codified in the ophthalmology literature primarily through the ETDRS studies of the 1980s, which formally established the staging criteria still used today.

---

ALIASES / ABBREVIATIONS / RELATED TERMS

Term	Meaning
NPDR	Standard abbreviation for nonproliferative diabetic retinopathy
Background retinopathy	Older synonym; still used clinically
PDR	Proliferative diabetic retinopathy — the advanced stage (neovascularization present)
DME	Diabetic macular edema — can co-exist with any NPDR stage
CSME	Clinically significant macular edema — older ETDRS term for vision-threatening DME
Microaneurysm	Earliest funduscopic finding; tiny focal outpouching of capillary wall
IRMA	Intraretinal microvascular abnormality — dilated, tortuous capillary shunts; marker of severe NPDR
Cotton-wool spot	Focal nerve fiber layer infarct from capillary occlusion; appears fluffy/white on fundus exam
Venous beading	Irregular dilation of retinal veins; sign of severe NPDR
Hard exudates	Lipid/protein deposits from leaking vessels; yellow waxy deposits near macula
Anti-VEGF	Class of drugs (aflibercept, ranibizumab, bevacizumab) that block the neovascularization trigger
ETDRS	Early Treatment Diabetic Retinopathy Study — defines the standard NPDR staging scale
HbA1c	Glycated hemoglobin — primary marker of long-term glycemic control; key risk factor
OCT	Optical coherence tomography — gold standard imaging for detecting and monitoring DME

---

CODING CONTEXT — ICD-10-CM/CPT

⚠️ Critical ICD-10 Coding Rule for Diabetic Retinopathy: In ICD-10-CM, diabetic retinopathy is always coded within the diabetes category (E10.-, E11.-, etc.) — never as a standalone retinal code. The diabetes code captures both the underlying condition and its manifestation. Laterality is required at the 7th character level. Do not additionally assign a separate H-code for the retinopathy unless a distinct, unrelated retinal condition also exists.

ICD-10 Code Structure for NPDR: E[DM type].[stage][macular edema flag][laterality]

• 5th digit: Type of NPDR (3 = mild, 4 = moderate, 5 = severe — within the retinopathy subcategory)
• 6th digit: 1 = with macular edema; 9 = without macular edema
• 7th digit: 1 = right eye; 2 = left eye; 3 = bilateral; 9 = unspecified eye

---

Type 2 Diabetes (E11) — Mild NPDR

ICD-10	Description
E11.3211	Type 2 DM, mild NPDR with macular edema, right eye
E11.3212	Type 2 DM, mild NPDR with macular edema, left eye
E11.3213	Type 2 DM, mild NPDR with macular edema, bilateral
E11.3219	Type 2 DM, mild NPDR with macular edema, unspecified eye
E11.3291	Type 2 DM, mild NPDR without macular edema, right eye
E11.3292	Type 2 DM, mild NPDR without macular edema, left eye
E11.3293	Type 2 DM, mild NPDR without macular edema, bilateral
E11.3299	Type 2 DM, mild NPDR without macular edema, unspecified eye

Type 2 Diabetes (E11) — Moderate NPDR

ICD-10	Description
E11.3311	Type 2 DM, moderate NPDR with macular edema, right eye
E11.3312	Type 2 DM, moderate NPDR with macular edema, left eye
E11.3313	Type 2 DM, moderate NPDR with macular edema, bilateral
E11.3319	Type 2 DM, moderate NPDR with macular edema, unspecified eye
E11.3391	Type 2 DM, moderate NPDR without macular edema, right eye
E11.3392	Type 2 DM, moderate NPDR without macular edema, left eye
E11.3393	Type 2 DM, moderate NPDR without macular edema, bilateral
E11.3399	Type 2 DM, moderate NPDR without macular edema, unspecified eye

Type 2 Diabetes (E11) — Severe NPDR

ICD-10	Description
E11.3411	Type 2 DM, severe NPDR with macular edema, right eye
E11.3412	Type 2 DM, severe NPDR with macular edema, left eye
E11.3413	Type 2 DM, severe NPDR with macular edema, bilateral
E11.3419	Type 2 DM, severe NPDR with macular edema, unspecified eye
E11.3491	Type 2 DM, severe NPDR without macular edema, right eye
E11.3492	Type 2 DM, severe NPDR without macular edema, left eye
E11.3493	Type 2 DM, severe NPDR without macular edema, bilateral
E11.3499	Type 2 DM, severe NPDR without macular edema, unspecified eye

Type 1 Diabetes (E10) — Parallel Structure (Same 7-character laterality pattern — substitute E10 for E11)

ICD-10	Description
E10.3291	Type 1 DM, mild NPDR without macular edema, right eye
E10.3292	Type 1 DM, mild NPDR without macular edema, left eye
E10.3391	Type 1 DM, moderate NPDR without macular edema, right eye
E10.3392	Type 1 DM, moderate NPDR without macular edema, left eye
E10.3411	Type 1 DM, severe NPDR with macular edema, right eye
E10.3491	Type 1 DM, severe NPDR without macular edema, right eye

Unspecified / Nonbillable (avoid — use specific codes above)

ICD-10	Description
E11.319	Type 2 DM, unspecified diabetic retinopathy, without macular edema (use only when staging not documented)
E10.319	Type 1 DM, unspecified diabetic retinopathy, without macular edema

Additional Codes (code additionally when documented)

ICD-10	Description
Z79.4	Long-term (current) use of insulin
Z79.84	Long-term (current) use of oral hypoglycemic drugs
Z79.85	Long-term (current) use of injectable non-insulin antidiabetic drugs

---

Retinal Imaging / Diagnostics

CPT	Description
92134	Scanning computerized ophthalmic diagnostic imaging, posterior segment; retina (OCT) — gold standard for DME monitoring
92250	Fundus photography with interpretation and report — documents retinal findings, tracks disease progression
92235	Fluorescein angiography (FA) with interpretation and report — maps retinal perfusion, identifies areas of ischemia/leakage
92240	Indocyanine-green (ICG) angiography with interpretation and report
92242	FA + ICG angiography combined
92227	Remote imaging for detection of retinal disease; image acquisition and transmission, unilateral or bilateral, with interpretation by a physician or QHP
92228	Remote imaging for monitoring of retinal disease; image acquisition and transmission, unilateral or bilateral, with interpretation by a physician or QHP
92229	Imaging of retina for detection or monitoring of disease; point-of-care automated analysis, unilateral or bilateral, with interpretation by physician or QHP

Eye Exams

CPT	Description
92004	Ophthalmological services, new patient — comprehensive, one or more visits
92014	Ophthalmological services, established patient — comprehensive, one or more visits

Treatment — Anti-VEGF Intravitreal Injections (for DME)

CPT	Description
67028	Intravitreal injection of a pharmacologic agent (anti-VEGF: aflibercept, ranibizumab, bevacizumab; or steroid: triamcinolone, dexamethasone implant)

Laser Treatment (for DME — less common since anti-VEGF era)

CPT	Description
67210	Destruction of localized lesion of retina; photocoagulation — focal/grid laser for DME

---

Key Coding Tips

• Laterality is mandatory — always code to the 7th character specifying right (1), left (2), bilateral (3), or unspecified (9). Unspecified eye codes risk payer denial.
• Macular edema status must be documented — the 6th character flip (e.g., E11.3311 vs. E11.3391) represents a clinically and financially significant distinction. Always verify with the operative/encounter note.
• E11.319 (unspecified retinopathy) should only be used when the provider has not documented the stage — it is not preferred and will not satisfy HCC capture requirements.
• NCCI bundles 92134 and 92250 — do not report both on the same date without modifier -59 and a documented distinct medical necessity for each (e.g., OCT for DME and fundus photography for a separate choroidal finding).
• 67028 (intravitreal injection) is bundled with many retinal laser procedures — confirm NCCI edits before billing together.
• Long-term insulin use (Z79.4) and oral hypoglycemic use (Z79.84) should be coded additionally per ICD-10-CM instructional notes under the E10-E11 categories.
• For inpatient coding (ICD-10-PCS): the retinal procedure (intravitreal injection, laser) requires a PCS procedure code from the Eye (0) body system, root operation Introduction or Destruction.
• Severity of NPDR directly affects HCC mapping and RAF scores in risk-adjustment models — accurate severity coding (mild/moderate/severe) is essential for value-based care programs.

---

DERIVATIONS of nonproliferative diabetic retinopathy

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(roots, (word) => econtains([[]].roots, word))) > 0 AND file.name != [[]].file.name
SORT file.name ASC

---

Query functionality

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(definition, (word) => econtains([[]].definition, word))) > 0 AND file.name != [[]].file.name

Med roots Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms